Skip to content

ALEXION PHARMACEUTICALS, INC.

CIK 0000899866

← back to feed
Revenue (TTM)
$6.11B
+0.2% YoY Q1 Apr 2021
Net Income (TTM)
$703.6M
−7.3% YoY Q1 Apr 2021
EPS Diluted (TTM)
$3.14
−7.6% YoY Q1 Apr 2021
Gross Margin
23.5%
Q1 Apr 2021
Operating Margin
10.6%
Q1 Apr 2021
Net Margin
11.5%
Q1 Apr 2021
Free Cash Flow (TTM)
$1.78B
Q1 Apr 2021
Cash
$3.43B
Q1 Apr 2021
Total Debt
$2.53B
Q1 Apr 2021
Shares Outstanding
221.02M sh
Q1 Apr 2021

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings